+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous Solutions Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 115 Pages
  • May 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5807558
Description Jump to:
Intravenous Solutions Market is expected to grow at 8.0% by 2031. Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in the Asia-Pacific region. Intravenous products are highly regulated for quality and availability assurance. Though matured, this market has been undergoing continuous evolution, thus experiencing steady growth.

The intravenous solutions manufacturers and vendors worldwide are perpetually improving the nature of products, and sales and distribution methods respectively. Several large players have employed direct sales force and independent distributors, retail and wholesalers. Alternate modes of supply are also employed by the manufacturers to retain profitability. Third parties that store and deliver products for the manufacturer have a significant foothold in developed markets. These type of vendors are found to better cater swift customer service as they always stock adequate inventories. Other sales practices in this market include sales through customer and sales service representatives, catalogue circulation and merchandising, electronic purchase facility and allied benefits, e-mail campaign, publicity through trade publications and trade fairs and others.

Market Players

Amanta Healthcare Ltd., Axa Parenterals Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eurolife Healthcare Pvt Ltd.,Fresenius Kabi AG, Grifols S.A, Henry Schein Inc., ICU Medical, Inc., JW Life Science, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., Salius Pharma Private Limited, Sichuan Kelun Pharmaceutical Co. Ltd, Soxa Formulations & Research (Pvt.) Ltd., Vifor Pharma Management Ltd. And Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Intravenous Solutions market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Intravenous Solutions market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Partial Parenteral Nutrition
  • Age Group
  • Pediatric
  • Adult
  • Total Parenteral Nutrition
  • Age Group
  • Pediatric
  • Adult

Composition

  • Carbohydrates
  • Vitamins and Minerals
  • Single Dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

End Users

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Home care settings

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Intravenous Solutions market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Intravenous Solutions market?
  • Which is the largest regional market for Intravenous Solutions market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Intravenous Solutions market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Intravenous Solutions market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Intravenous Solutions Market
2.2. Global Intravenous Solutions Market, By Type, 2022 (US$ Million)
2.3. Global Intravenous Solutions Market, By Composition, 2022 (US$ Million)
2.4. Global Intravenous Solutions Market, By End Users, 2022 (US$ Million)
2.5. Global Intravenous Solutions Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022
3. Intravenous Solutions Market: Competitive Analysis
3.1. Market Positioning of Key Intravenous Solutions Market Vendors
3.2. Strategies Adopted by Intravenous Solutions Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Intravenous Solutions Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Intravenous Solutions Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Partial Parenteral Nutrition
5.3.1.1. Age Group
5.3.1.1.1. Pediatric
5.3.1.1.2. Adult
5.3.2. Total Parenteral Nutrition
5.3.2.1. Age Group
5.3.2.1.1. Pediatric
5.3.2.1.2. Adult
6. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Carbohydrates
6.3.2. Vitamins and Minerals
6.3.3. Single Dose Amino Acids
6.3.4. Parenteral Lipid Emulsion
6.3.5. Others
7. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Hospitals and Clinics
7.3.2. Ambulatory Surgery Centers
7.3.3. Home care settings
8. North America Intravenous Solutions Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
8.3. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
8.4. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
8.5.Intravenous Solutions Market: By Region, 2021-2031, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
8.5.1.1.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
8.5.1.1.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
8.5.1.2.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
8.5.1.2.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
8.5.1.3.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
8.5.1.3.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9. UK and European Union Intravenous Solutions Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.3. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.4. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.Intravenous Solutions Market: By Region, 2021-2031, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.1.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.1.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.2.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.2.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.3.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.3.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.4.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.4.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.1.5. France
9.5.1.5.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.5.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.5.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
9.5.1.6.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
9.5.1.6.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10. Asia Pacific Intravenous Solutions Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.3. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.4. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.Intravenous Solutions Market: By Region, 2021-2031, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.1.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.1.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.2.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.2.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.1.3. India
10.5.1.3.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.3.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.3.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.4.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.4.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.5.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.5.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
10.5.1.6.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
10.5.1.6.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
11. Latin America Intravenous Solutions Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
11.3. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
11.4. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
11.5.Intravenous Solutions Market: By Region, 2021-2031, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
11.5.1.1.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
11.5.1.1.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
11.5.1.2.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
11.5.1.2.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
11.5.1.3.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
11.5.1.3.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
12. Middle East and Africa Intravenous Solutions Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
12.3. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
12.4. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
12.5.Intravenous Solutions Market: By Region, 2021-2031, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
12.5.1.1.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
12.5.1.1.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
12.5.1.2.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
12.5.1.2.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Intravenous Solutions Market: By Type, 2021-2031, USD (Million)
12.5.1.3.1. Intravenous Solutions Market: By Composition, 2021-2031, USD (Million)
12.5.1.3.1. Intravenous Solutions Market: By End Users, 2021-2031, USD (Million)
13. Company Profile
13.1. Amanta Healthcare Ltd.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Axa Parenterals Ltd.,
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. B. Braun Melsungen AG
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Baxter International Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Becton, Dickinson and Company
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Eurolife Healthcare Pvt Ltd.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Fresenius Kabi AG
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Grifols S.A
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Henry Schein Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. ICU Medical, Inc.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. JW Life Science
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Otsuka Pharmaceutical Co., Ltd.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Pfizer, Inc.
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Salius Pharma Private Limited
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Sichuan Kelun Pharmaceutical Co. Ltd
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Soxa Formulations & Research (Pvt.) Ltd.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Vifor Pharma Management Ltd.
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
13.18. Other Notable Players
13.18.1. Company Overview
13.18.2. Financial Performance
13.18.3. Product Portfolio
13.18.4. Strategic Initiatives
List of Figures
Figure. 1 Global Intravenous Solutions Market: Market Coverage
Figure. 2 Research Methodology and Data Sources
Figure. 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure. 4 Global Intravenous Solutions Market: Quality Assurance
Figure. 5 Global Intravenous Solutions Market, By Type, 2022
Figure. 6 Global Intravenous Solutions Market, By Composition, 2022
Figure. 7 Global Intravenous Solutions Market, By End Users, 2022
Figure. 8 Global Intravenous Solutions Market, By Geography, 2022
Figure. 9 Market Geographical Opportunity Matrix - Global Intravenous Solutions Market, 2022
Figure. 10 Market Positioning of Key Intravenous Solutions Market Players, 2022
Figure. 11 Global Intravenous Solutions Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure. 12 Global Intravenous Solutions Market, By Type, 2022 Vs 2031, %
Figure. 13 Global Intravenous Solutions Market, By Composition, 2022 Vs 2031, %
Figure. 14 Global Intravenous Solutions Market, By End Users, 2022 Vs 2031, %
Figure. 15 U.S. Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 16 Canada Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 17 Rest of North America Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 18 UK Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 19 Germany Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 20 Spain Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 21 Italy Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 22 France Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 23 Rest of Europe Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 24 China Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 25 Japan Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 26 India Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 27 Australia Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 28 South Korea Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 29 Rest of Asia Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 30 Brazil Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 31 Mexico Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 32 Rest of Latin America Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 33 GCC Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 34 Africa Intravenous Solutions Market (US$ Million), 2021 - 2031
Figure. 35 Rest of Middle East and Africa Intravenous Solutions Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 2 Global Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 3 Global Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 4 Global Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 5 Global Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 6 Global Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 7 Global Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 8 North America Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 9 North America Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 10 North America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 11 North America Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 12 North America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 13 North America Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 14 North America Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 15 U.S. Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 16 U.S. Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 17 U.S. Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 18 U.S. Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 19 U.S. Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 20 U.S. Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 21 U.S. Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 22 Canada Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 23 Canada Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 24 Canada Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 25 Canada Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 26 Canada Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 27 Canada Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 28 Canada Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 29 Rest of North America Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 30 Rest of North America Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 31 Rest of North America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 32 Rest of North America Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 33 Rest of North America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 34 Rest of North America Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 35 Rest of North America Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 36 UK and European Union Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 37 UK and European Union Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 38 UK and European Union Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 39 UK and European Union Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 40 UK and European Union Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 41 UK and European Union Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 42 UK and European Union Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 43 UK Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 44 UK Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 45 UK Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 46 UK Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 47 UK Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 48 UK Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 49 UK Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 50 Germany Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 51 Germany Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 52 Germany Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 53 Germany Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 54 Germany Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 55 Germany Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 56 Germany Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 57 Spain Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 58 Spain Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 59 Spain Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 60 Spain Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 61 Spain Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 62 Spain Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 63 Spain Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 64 Italy Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 65 Italy Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 66 Italy Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 67 Italy Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 68 Italy Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 69 Italy Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 70 Italy Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 71 France Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 72 France Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 73 France Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 74 France Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 75 France Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 76 France Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 77 France Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 78 Rest of Europe Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 79 Rest of Europe Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 80 Rest of Europe Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 81 Rest of Europe Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 82 Rest of Europe Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 83 Rest of Europe Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 84 Rest of Europe Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 85 Asia Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 86 Asia Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 87 Asia Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 88 Asia Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 89 Asia Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 90 Asia Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 91 Asia Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 92 China Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 93 China Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 94 China Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 95 China Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 96 China Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 97 China Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 98 China Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 99 Japan Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 100 Japan Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 101 Japan Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 102 Japan Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 103 Japan Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 104 Japan Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 105 Japan Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 106 India Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 107 India Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 108 India Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 109 India Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 110 India Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 111 India Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 112 India Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 113 Australia Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 114 Australia Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 115 Australia Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 116 Australia Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 117 Australia Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 118 Australia Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 119 Australia Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 120 South Korea Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 121 South Korea Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 122 South Korea Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 123 South Korea Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 124 South Korea Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 125 South Korea Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 126 South Korea Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 127 Latin America Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 128 Latin America Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 129 Latin America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 130 Latin America Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 131 Latin America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 132 Latin America Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 133 Latin America Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 134 Brazil Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 135 Brazil Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 136 Brazil Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 137 Brazil Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 138 Brazil Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 139 Brazil Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 140 Brazil Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 141 Mexico Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 142 Mexico Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 143 Mexico Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 144 Mexico Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 145 Mexico Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 146 Mexico Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 147 Mexico Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 148 Rest of Latin America Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 149 Rest of Latin America Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 150 Rest of Latin America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 151 Rest of Latin America Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 152 Rest of Latin America Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 153 Rest of Latin America Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 154 Rest of Latin America Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 155 Middle East and Africa Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 156 Middle East and Africa Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 157 Middle East and Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 158 Middle East and Africa Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 159 Middle East and Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 160 Middle East and Africa Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 161 Middle East and Africa Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 162 GCC Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 163 GCC Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 164 GCC Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 165 GCC Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 166 GCC Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 167 GCC Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 168 GCC Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 169 Africa Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 170 Africa Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 171 Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 172 Africa Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 173 Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 174 Africa Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 175 Africa Intravenous Solutions Market By End Users, 2021-2031, USD (Million)
Table 176 Rest of Middle East and Africa Intravenous Solutions Market By Type, 2021-2031, USD (Million)
Table 177 Rest of Middle East and Africa Intravenous Solutions Market By Partial Parenteral Nutrition, 2021-2031, USD (Million)
Table 178 Rest of Middle East and Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 179 Rest of Middle East and Africa Intravenous Solutions Market By Total Parenteral Nutrition, 2021-2031, USD (Million)
Table 180 Rest of Middle East and Africa Intravenous Solutions Market By Age Group, 2021-2031, USD (Million)
Table 181 Rest of Middle East and Africa Intravenous Solutions Market By Composition, 2021-2031, USD (Million)
Table 182 Rest of Middle East and Africa Intravenous Solutions Market By End Users, 2021-2031, USD (Million)

Companies Mentioned

  • Amanta Healthcare Ltd.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Dickinson and Company
  • Eurolife Healthcare Pvt Ltd.
  • Fresenius Kabi AG
  • Grifols S.A
  • Henry Schein Inc.
  • ICU Medical Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co.
  • Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited
  • Sichuan Kelun Pharmaceutical Co. Ltd
  • Soxa Formulations & Research (Pvt.) Ltd.
  • Vifor Pharma Management Ltd

Related Topics

Related Reports

Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Global Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element) - Forecast 2024-2030 - Product Image

Global Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) by Region (Asia Pacific, North America), and Segment Forecasts, 2024-2030 - Product Image

Global Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) by Region (Asia Pacific, North America), and Segment Forecasts, 2024-2030

  • Report
  • 114 Pages
  • Global
From
Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032 - Product Image

Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Global Intravenous Solutions Market Analysis & Forecast to 2024-2034 - Product Image

Global Intravenous Solutions Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.